Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients.

AIDS (London, England) - 4 May 2001

Zöllner B, Feucht H H, Schröter M, Schäfer P, Plettenberg A, Stoehr A, Laufs R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Cross-Sectional Studies
Share to Drug Resistance, Microbial
Share to Enfuvirtide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Envelope Protein gp41

Share to HIV Infections

Share to Peptide Fragments

Source

Identifiers

PMID: 11399967
DOI: 10.1097/00002030-200105040-00015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients.PMID 11399967Read ↗

HIV genetic mutations causing resistance to the new drug T-20: recent findings.Semantic proximity Read ↗

Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20.Semantic proximity Read ↗

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.Semantic proximity Read ↗

Primary resistance to enfuvirtide (T20) in recently HIV-1 infected, antiretroviral-naive patients from the ANRS Aquitaine Cohort.Semantic proximity Read ↗

Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1.Semantic proximity Read ↗

Design of Novel HIV-1/2 Fusion Inhibitors with High Therapeutic Efficacy in Rhesus Monkey ModelsSemantic proximity Read ↗

Emergence of a Drug-Dependent Human Immunodeficiency Virus Type 1 Variant during Therapy with the T20 Fusion InhibitorSemantic proximity Read ↗

Transmission of HIV-1 variants resistant to the three classes of antiretroviral agents: implications for HIV therapy in primary infection.Semantic proximity Read ↗

Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients.Semantic proximity Read ↗

Baseline Susceptibility of Primary Human Immunodeficiency Virus Type 1 to Entry InhibitorsSemantic proximity Read ↗

Human immunodeficiency virus type 1 variants resistant to first- and second-version fusion inhibitors and cytopathic in ex vivo human lymphoid tissue.Semantic proximity Read ↗

Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.